Dual-action inhibitors of Tie2 and KDR kinase prepared and tested at Bayer Schering Pharma Jan. 27, 2009
Novel inhibitors of bacterial DNA gyrase and/or topoisomerase type 4 prepared and tested Jan. 26, 2009